| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenues | $636.6M-10.2% | $709.3M-20.2% | $888.4M+13.7% | $781.6M |
| Cost of sales | $501.5M-8.8% | $549.7M-18.3% | $672.5M+8.2% | $621.3M |
| Depreciation and amortization | $95.2M+1.3% | $94.0M+29.1% | $72.8M+28.2% | $56.8M |
| Selling, general and administrative | $68.5M-13.9% | $79.6M-8.2% | $86.7M+23.2% | $70.4M |
| Research and development costs | $1.7M+21.4% | $1.4M+0.0% | $1.4M+133.3% | $600K |
| Impairment and other charges | $0-100.0% | $100K | $0 | — |
| Operating loss | -$30.3M-95.5% | -$15.5M-127.2% | $56.9M+75.1% | $32.5M |
| Interest income | -$400K+84.0% | -$2.5M-38.9% | -$1.8M | $0 |
| Interest expense | $45.2M+14.7% | $39.4M+7.9% | $36.5M+4.3% | $35.0M |
| Loss on debt extinguishment | $1.2M | $0 | — | — |
| Net loss before income tax | -$76.3M-45.6% | -$52.4M-336.0% | $22.2M+988.0% | -$2.5M |
| Income tax expense | $800K+33.3% | $600K-80.0% | $3.0M+400.0% | $600K |
| Net loss | -$77.1M-45.5% | -$53.0M-376.0% | $19.2M+719.4% | -$3.1M |
| Net loss per share - basic (in dollars per share) | -$4.12-26.0% | -$3.27-365.9% | $1.23+555.6% | -$0.27 |
| Net loss per share - diluted (in dollars per share) | -$4.12-26.0% | -$3.27-368.0% | $1.22+551.9% | -$0.27 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.